Darifenacin Hydrobromide
4 NDCs across 1 manufacturer|4 Generic,0 Brand
Darifenacin Hydrobromide is used to treat overactive urinary bladder and urge urinary incontinence, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 22, 2004, and the first generic was approved Mar 13, 2015. FDA's Orange Book lists 12 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $7 million on Darifenacin Hydrobromide across 38,000 claims for 10,000 beneficiaries.
Darifenacin Hydrobromide is available as 4 NDCs from 1 manufacturer (4 generic, 0 brand), with NADAC prices from $0.40 to $0.58 per EA — a 45% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
4G / 0B
Manufacturers
1
competing in market
Price Spread
$0.40 – $0.58
per EA
7d Activity
avg +1.0% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing DARIFENACIN HYDROBROMIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
DARIFENACIN ER 7.5 MG TABLET | $0.5762 per EA | -2.93% |
DARIFENACIN ER 7.5 MG TABLET | $0.5762 per EA | -2.93% |
DARIFENACIN ER 15 MG TABLET | $0.3971 per EA | +4.85% |
DARIFENACIN ER 15 MG TABLET | $0.3971 per EA | +4.85% |
Frequently Asked Questions
What is Darifenacin Hydrobromide used to treat?
Darifenacin Hydrobromide is used to treat overactive urinary bladder and urge urinary incontinence, per the National Library of Medicine's MED-RT classification.
When did Darifenacin Hydrobromide become available as a generic?
FDA approved the first generic Darifenacin Hydrobromide (ANDA) on Mar 13, 2015. The Orange Book currently lists 12 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Darifenacin Hydrobromide?
In 2024, Medicare Part D spent $7 million on Darifenacin Hydrobromide across 38,000 claims for 10,000 beneficiaries.
How many Darifenacin Hydrobromide products are on the market?
The Darifenacin Hydrobromide drug market contains 4 NDCs from 1 manufacturer — 4 generic and 0 brand products.
What is the price range for Darifenacin Hydrobromide?
NADAC reference prices for Darifenacin Hydrobromide range from $0.3971 to $0.5762 per EA — a 45% difference between cheapest and most expensive.
Which manufacturers make Darifenacin Hydrobromide?
1 manufacturer lists Darifenacin Hydrobromide in NADAC. Ranked by number of NDCs, the largest are Cipla USA Inc. (4).
How has the price of Darifenacin Hydrobromide changed recently?
Over the past 7 days, 2 Darifenacin Hydrobromide NDCs rose and 2 fell, with a market-wide average change of +1.0%.